Osaic Holdings’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.84M | Sell |
99,372
-9,526
| -9% | -$848K | 0.02% | 759 |
|
|
2025
Q1 | $8.83M | Buy |
108,898
+12,967
| +14% | +$1.05M | 0.02% | 743 |
|
|
2024
Q4 | $8.64M | Sell |
95,931
-29,950
| -24% | -$2.7M | 0.02% | 750 |
|
|
2024
Q3 | $12.4M | Buy |
125,881
+51,123
| +68% | +$5.05M | 0.03% | 586 |
|
|
2024
Q2 | $6.93M | Sell |
74,758
-9,081
| -11% | -$842K | 0.02% | 821 |
|
|
2024
Q1 | $7.96M | Buy |
83,839
+179
| +0.2% | +$17K | 0.02% | 796 |
|
|
2023
Q4 | $7.47M | Sell |
83,660
-22,986
| -22% | -$2.05M | 0.01% | 958 |
|
|
2023
Q3 | $7.79M | Buy |
106,646
+7,078
| +7% | +$517K | 0.01% | 1003 |
|
|
2023
Q2 | $8.3M | Sell |
99,568
-10,642
| -10% | -$887K | 0.01% | 863 |
|
|
2023
Q1 | $8.4M | Sell |
110,210
-12,183
| -10% | -$928K | 0.02% | 846 |
|
|
2022
Q4 | $10.2M | Buy |
122,393
+6,773
| +6% | +$562K | 0.02% | 731 |
|
|
2022
Q3 | $9.17M | Buy |
115,620
+8,002
| +7% | +$635K | 0.02% | 701 |
|
|
2022
Q2 | $8.02M | Sell |
107,618
-47,239
| -31% | -$3.52M | 0.02% | 780 |
|
|
2022
Q1 | $13.3M | Buy |
154,857
+57,850
| +60% | +$4.98M | 0.03% | 607 |
|
|
2021
Q4 | $10.9M | Sell |
97,007
-232
| -0.2% | -$26K | 0.02% | 703 |
|
|
2021
Q3 | $12.2M | Sell |
97,239
-17,462
| -15% | -$2.2M | 0.03% | 585 |
|
|
2021
Q2 | $15.5M | Sell |
114,701
-1,470
| -1% | -$199K | 0.03% | 469 |
|
|
2021
Q1 | $15.8M | Buy |
116,171
+9,966
| +9% | +$1.35M | 0.04% | 420 |
|
|
2020
Q4 | $15M | Buy |
106,205
+15,260
| +17% | +$2.15M | 0.04% | 398 |
|
|
2020
Q3 | $10.1M | Sell |
90,945
-10,909
| -11% | -$1.22M | 0.03% | 463 |
|
|
2020
Q2 | $11.4M | Buy |
101,854
+13,697
| +16% | +$1.53M | 0.04% | 398 |
|
|
2020
Q1 | $5.72M | Buy |
+88,157
| New | +$5.72M | 0.02% | 549 |
|